Skip to content

The effect of hydroxyzine hydrochloride on intrathecal morphine-induced pruritus for cesarean delivery- A randomized control study

The effect of hydroxyzine hydrochloride on intrathecal morphine-induced pruritus - The effect of hydroxyzine hydrochloride on intrathecal morphine-induced pruritus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050981
Enrollment
80
Registered
2023-05-02
Start date
2021-02-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean delivery

Interventions

Intravenous hydroxyzine hydrochloride 25mg right after delivery of the placenta Intravenous 0.9% saline right after delivery of the placenta

Sponsors

National Hospital Organization Miyakonojo Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)Patients did not give consent. 2)Had no time for explanation, (3) used an antihistamine drug, pentazocine before surgery or (4) had an allergy to hydroxyzine, morphine, fentanyl, or bupivacaine. Patients were excluded if they (1) did not give consent, (2) had no time for explanation, (3) used an antihistamine drug, pentazocine before surgery or (4) had an allergy to hydroxyzine, morphine, fentanyl, or bupivacaine.

Exclusion criteria

Exclusion criteria: 1)Extremely emergent cesarean section 2)Patients who have been using an antihistamine drug or pentazocine before surgery 3)Patients who have an allergy to hydroxyzine, morphine, fentanyl, or bupivacaine

Design outcomes

Primary

MeasureTime frame
The severity of pruritus within 24 hours

Secondary

MeasureTime frame
Postoperative pain and PONV within 24 hours

Countries

Japan

Contacts

Public ContactShuji Uchimura

National Hospital Organization Miyakonojo Medical Center Department of Anesthesiology

syuji_uchimura@med.miyazaki-u.ac.jp0986-23-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026